The objective of chronic myeloid leukemia treatment is to remove the platelets that contain the strange BCR-ABL gene that causes the high number of infected platelets. For the vast majority, it's unrealistic to dispose of every sick cell, yet treatment can accomplish a long haul remission of the disease. The meds utilized for patients with ceaseless (Chronic) stage interminable myelogenous leukemia (CML) go for postponing the onset of the quickened or blastic phase. This has generally incorporated a myelosuppressive operator to accomplish hematologic abatement, yet more compelling medications-progressively, interferon Alfa then and focused on treatment with tyrosine kinase inhibitors, for example, imatinib mesylate, have increased more noteworthy significance. Imatinib is a protein-tyrosine kinase inhibitor. It works by keeping the development of malignancy cells.